Sureflo2
Combining design and clinical expertise
SureflO2 - Making the invisible visible
SureflO2 – traditional oxygen masks reimagined


SureflO2

Developed in response to a preventable issue in clinical care, the SureflO2 indicator provides clear visual confirmation of gas flow to patients requiring supplemental oxygen.

Confidence that patients are receiving the supplemental oxygen they require.

For healthcare workers, an easy to use safety indicator allows monitoring from a distance.

WATCH:
From concept to clinical use …

SureflO2

– from the initial spark of an idea and concept, the creation of a prototype, production and manufacture in Australia to … finally its use in clinical care.

WATCH:
SureflO2 & Anaesthetist Dr Matt Matusik
– profile by St Vincent’s Hospital Fitzroy …

SureflO2

– St Vincent’s Hospital, Fitzroy receives the first hospital delivery of TGA approved SureflO2 oxygen masks.

SureflO2

Our Team

Dr Matthew Matusik MBBS, FANZCA (Specialist Anaesthetist)

Dr Matthew Matusik

MBBS, FANZCA
(Specialist Anaesthetist)

St Vincents Hospital Melbourne, Australia.
Inventor & codeveloper of SureflO2

Mr Paul Smith MBBS, PhD, FRACS, GDEB (Neurosurgeon)

Mr Paul Smith

MBBS, PhD, FRACS, GDEB
(Neurosurgeon)

St Vincents Hospital Melbourne, Australia
Codeveloper of SureflO2

News

Channel 7 News - Breathe Easy May 10 2020

7 NEWS Melbourne: “Breathe Easy”

MAY 2020

SureflO2 Flow Indicator Oxygen Mask – featured on Channel 7 News Melbourne Segment “Breathe Easy”
– May 10 2020

“A Melbourne doctor has reinvented an age-old piece of medical equipment to help patients breathe a little easier He’s spent eight years perfecting an oxygen mask which is set to save lives.”
View the news segment on Channel 7 Facebook

https://www.facebook.com/7NEWSMelbourne/videos/1622670031231056/

TGA Approval

APRIL 2020

SureflO2 Flow Indicator Oxygen Mask gains approval from the Australian Therapeutics Goods Administration (TGA).

The SureflO2 – oxygen therapy delivery system has reached an important milestone and has successfully gained approval from the TGA and has been included into the Australian Register of Therapeutic Goods (ARTG) as a Class IIa medical device intended to provide visual confirmation of presence (or absence) of gas flow into an oxygen mask.

SureflO2 flow indicator mask gains CE Certification and European approval - March 2020

CE Certification

MARCH 2020

SureflO2 Flow Indicator Oxygen Mask receives CE Certification indicating that it has been designed and manufactured according to all applicable safety and performance standards for products sold within the European Economic Area (EEA).

CE Certificate
(Production Quality Assurance)

SureflO2 Flow Indicator Oxygen Mask (class IIa)

Mat Matusik & Paul Smith accepted as a Finalist in Clinical Innovation category for SureflO2 - SVHA 2007 Innovation & Excellence Awards

FINALIST: 2017 SVHA Innovation & Excellence Awards

SEPT 2017

St Vincent’s Health Australia recognises SureflO2 as a Finalist in the  Clinical Innovation Category  as an aid to recognising and preventing failure of supplemental oxygen delivery via a face mask.

https://www.svha.org.au/newsroom/svha-newsletter/september-2017

Clinical observation where it matters…

the airway